We have previously reported that mTORC2 is a critical driver of metabolic as well as epigenetic reprogramming in cancer cells [20], and we thus hypothesized that the expression of DNMT3A might be epigenetically regulated by mTORC2. This evidence concerns the gene DNMT3A and cancer.